Insider · CIK 0001749432
Shawnte Mitchell
Files at OLMA (Olema Pharmaceuticals, Inc.). First filing Mar 5, 2026, latest Mar 5, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
OLMA: Olema Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 44Moderate | OLMAsell Olema Pharmaceuticals, Inc. | $952k 40,000 shares | -267% | +666% from low-35% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | OLMA Olema Pharmaceuticals, Inc. | MOption exercise Common Stock | +15,000 | $4.37 | $66k | 15,000 | Mar 5, 2026 |
| Mar 3, 2026 | OLMA Olema Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -15,000 | $23.01 | $345k | 0 | Mar 5, 2026 |
| Mar 4, 2026 | OLMA Olema Pharmaceuticals, Inc. | MOption exercise Common Stock | +25,000 | $4.37 | $109k | 25,000 | Mar 5, 2026 |
| Mar 4, 2026 | OLMA Olema Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -24,767 | $24.25 | $601k | 233 | Mar 5, 2026 |
| Mar 4, 2026 | OLMA Olema Pharmaceuticals, Inc. | SOpen-market sale Comon Stock | -233 | $24.69 | $5,753 | 0 | Mar 5, 2026 |
| Mar 3, 2026 | OLMA Olema Pharmaceuticals, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -15,000 | $0.00 | $0 | 435,000 | Mar 5, 2026 |
| Mar 4, 2026 | OLMA Olema Pharmaceuticals, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -25,000 | $0.00 | $0 | 410,000 | Mar 5, 2026 |
| Feb 2, 2026 | OLMA Olema Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +220,000 | $0.00 | $0 | 220,000 | Feb 4, 2026 |
| Feb 2, 2026 | OLMA Olema Pharmaceuticals, Inc. | AGrant or award Performance Stock Options (Right to Buy)derivative | +56,250 | $0.00 | $0 | 56,250 | Feb 4, 2026 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.